Related references
Note: Only part of the references are listed.Renal side effects of adefovir in hepatitis B virus-(HBV) positive kidney allograft recipients
N. Kamar et al.
CLINICAL NEPHROLOGY (2013)
Response to adefovir or entecavir in renal allograft recipients with hepatitic flare due to lamivudine-resistant hepatitis B
Kai Chung Tse et al.
CLINICAL TRANSPLANTATION (2010)
Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus
A. Tamori et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Adefovir dipivoxil-induced acute tubular necrosis and Fanconi syndrome in a renal transplant patient
Hassane Izzedine et al.
AIDS (2009)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
Patrick Marcellin et al.
JOURNAL OF HEPATOLOGY (2009)
Treatment of lamivudine-resistant hepatitis B infection in post-renal transplant patients with adefovir dipivoxil: Premiminary results
H. J. de Silva et al.
TRANSPLANTATION PROCEEDINGS (2006)
Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy
Florian van Boemmel et al.
HEPATOLOGY (2006)
Lamivudine therapy for hepatitis B infection in post-renal transplant patients: results after 36 months follow-up
HJ De Silva et al.
LIVER INTERNATIONAL (2005)
Antiviral drug-induced nephrotoxicity
H Izzedine et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: Two double-blind, randomized, placebo-controlled studies
H Izzedine et al.
KIDNEY INTERNATIONAL (2004)
Lamivudine therapy in renal allograft recipients with hepatitis B virus infection
WK Tsang et al.
TRANSPLANTATION PROCEEDINGS (2003)
Adefovir nephrotoxicity: Possible role of mitochondrial DNA depletion
N Tanji et al.
HUMAN PATHOLOGY (2001)
Chronic hepatitis B treatment with lamivudine in kidney transplant patients
C Mouquet et al.
TRANSPLANTATION PROCEEDINGS (2000)
Share Paper
